SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the official completion of a major at-the-market share offering and the successful funding of its planned Iridium acquisition, a development that investors note removes a significant financing risk. Community reaction is mixed, with bulls viewing the de-risked balance sheet as a catalyst for future growth, while some traders remain skeptical due to broader market volatility and concerns over long-term profitability.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the announcement that the final efficacy analysis of the Phase 3 ORIGIN 3 trial for TRUTAKNA (atacicept) met all primary and secondary endpoints, including stabilizing renal function (eGFR) and reducing disease progression. While some traders debate the commercial impact given the drug's existing accelerated approval, bulls highlight the positive long-term safety and efficacy data as a catalyst for full FDA approval, while others monitor for potential short-squeeze activity due to significant short interest.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is attracting attention following record fiscal fourth-quarter results, characterized by significant growth in revenue, bookings, and a record backlog. Investors remain highly bullish on the company's FY27 guidance and expansion plans, though some traders express caution regarding the potential impact of share offerings on the stock's near-term performance.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's shares sank after the company reported a surprise second-quarter loss and missed revenue expectations, leading to a wave of price target cuts from multiple analysts. While retail traders remain divided, some are expressing optimism regarding the CEO's "Back-to-Basics" turnaround strategy and early signs of improving sales trends.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending due to anticipation of its upcoming merger with Agility Robotics, which investors view as a rare pure-play exposure to the growing humanoid robotics industry. Market sentiment is heavily bolstered by Agility's strategic partnerships with major tech firms, such as Amazon and Nvidia, and community members are actively debating the stock's valuation potential in light of broader robotics sector enthusiasm.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending primarily due to the presentation of positive Phase 3 data for plozasiran in patients with severe hypertriglyceridemia, which demonstrated significant reductions in triglycerides and acute pancreatitis events. While many traders are optimistic about the company's platform potential and future catalysts, others expressed frustration with price volatility and aggressive market-making activity in the options market.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is trending as investors await the upcoming earnings release, with discussion focused on the company's progress toward commercialization and the potential impact of its strategic photonics manufacturing agreements. Community sentiment remains divided between optimism over government-backed contracts and skepticism regarding the timeline for achieving meaningful commercial revenue.

Hub Cyber Security (Israel) Ltd. engages in the development of computer software and the establishment of quality and reliability systems. It operates through the following segments: Consulting, Software, Training, and Software Testing and Outsourcing. The Consulting segment provides engineering and management consulting services in the fields of management and establishment of quality and reliability systems, reliability and safety analyzes, improvement works of processes and products, risk analysis and management, writing procedures and analytical reports, certification of organizations and companies according to accepted standards. The Software segment engages in software development for calculating reliability and safety data, for collecting and reporting incidents and faults, as well as databases. The Training segment engages in trainings and certifications in the areas of quality, safety, reliability and as part of training for the IDF, in the fields of command, management, organizational behavior, and preparation for military service. The Software Testing and Outsourcing segment provides solutions and services in the fields of test engineering, formation and characterization of processes, establishment of test groups and laboratories, development of quality indices, implementation of test methodologies in accordance with the organization's strategy and placement of employees in the above fields. The company was founded by Zigmund Bluvband on June 13, 1984 and is headquartered in Tel Aviv, Israel.

Hub Cyber Security Ltd

Investors are focused on the company's execution of a 1-for-25 reverse stock split intended to maintain its Nasdaq listing, alongside ongoing concerns regarding dilution and the firm's financial stability. While some traders speculate on potential upward momentum and short-squeeze opportunities due to the low float, others remain highly skeptical, citing the company's history of multiple reverse splits and persistent lack of clear growth catalysts.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum is receiving attention as traders monitor its role in the Robinhood chain and increased activity in tokenized assets, with many debating the impact of token unlocks and fee-sharing potential. The community is split between bullish sentiment regarding its market position as a leading Layer 2 ecosystem and frustration over its price performance relative to the network's on-chain utility.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is seeing significant attention centered on anticipation for upcoming clinical trial data presentations and continued buyout speculation. While some investors are optimistic about the company's path to profitability and its pipeline potential, others express frustration with recent price volatility and perceived institutional manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DOCU Equibles has it in the filing data. Docusign, Inc. director Solvik Peter reported selling 30,000 DOCU shares on September 10, 2026, worth about $1.96 million, in a non-derivative Form 4.

StockTwits Web

DocuSign Inc

 Equibles has it in the filing data. Docusign, Inc. director Solvik Peter reported selling 30,000 DOCU shares on September 10, 2026, worth about $1.96 million, in a non-derivative Form 4.